Kitazawa T, Seino H, Ohashi H, Inazawa T, et al. Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus DPP-4 inhibitor in Japanese type 2 diabetes patients: a randomized, 24-week, open label, controlled trial (STOP-OB). Diabetes Obes Metab 2020 Apr 20. doi: 10.1111/dom.14059.
PMID: 32314464